J Int Soc Sports Nutr 2008,5(Suppl 1):28.CrossRef 18. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH: Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003,28(7):916–931.CrossRefPubMed 19. Roffey DM, Byrne NM, Hills AP: Day-to-day variance in measurement of resting metabolic rate using ventilated-hood and

mouthpiece & nose-clip indirect calorimetry systems. J Parenter Enteral Nutr 2006,30(5):426–432.CrossRef 20. Morales A: Yohimbine in erectile dysfunction: the facts. Int J Impot Res 2000,12(Suppl 1):S70–74.CrossRef 21. Gonzalez-Yanes C, Sanchez-Margalet V: Signaling mechanisms regulating lipolysis. Cell Signal 2006,18(4):401–408.CrossRef 22. https://www.selleckchem.com/products/epz-5676.html Taylor SS, Kim C, Cheng CY, Brown SH, Wu J, Kannan N: Signaling through cAMP and cAMP-dependent protein kinase: PRIMA-1MET diverse strategies for drug design. Biochim Biophys Acta 2008,1784(1):16–26.PubMed 23. Butcher RW, CE Baird, EW Sutherland: Effects of buy MDV3100 lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fat cells. J Biol Chem 1968,243(8):1705–12.PubMed 24. Carpéné C, Galitzky J, Fontana

E, Atgié C, Lafontan M, Berlan M: Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs DNA Damage inhibitor Arch Pharmacol 1999,359(4):310–21.CrossRefPubMed

25. Dourish CT, Boulton AA: The effects of acute and chronic administration of beta-phenylethylamine on food intake and body weight in rats. Prog Neuropsychopharmacol 1981,5(4):411–414.CrossRefPubMed 26. Paterson IA, Juorio AV, Boulton AA: 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system? J Neurochem 1990,55(6):1827–1837.CrossRefPubMed 27. Hapke HJ, W Strathmann: Pharmacological effects of hordenine. Dtsch Tierarztl Wochenschr 1995,102(6):228–32.PubMed 28. Berge RK, Hvattum E: Impact of cytochrome P450 system on lipoprotein metabolism. Effect of abnormal fatty acids (3-thia fatty acids). Pharmacol Ther 1994,61(3):345–83.CrossRefPubMed 29. Berge RK, Tronstad KJ, Berge K, Rost TH, Wergedahl H, Gudbrandsen OA, Skorve J: The metabolic syndrome and the hepatic fatty acid drainage hypothesis. Biochimie 2005,87(1):15–20.CrossRefPubMed Competing interests This study was financially supported by Vital Pharmaceuticals, Inc. Although the authors or the University of Memphis do not directly endorse the dietary supplement, the lead author (RJB) has been involved in scientific writing for Vital Pharmaceuticals, Inc.